Received Nov 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | YE232 | IM / AR |
NO REPORTED ADVERSE EFFECTS AT THIS TIME; REPORTING BECAUSE THE PATIENT HAD ALREADY PREVIOUSLY RECIEVED THE RSV VACCINE AT A DIFFERENT PHARMACY IN MARCH OF 2025
SODIUM CHLORIDE OPHT OINTMENT
NKDA